Novel thyrotropin-releasing hormone (TRH, pGlu-His-Pro-NH2) analogs, made b
y solid phase, were derived from the general scaffold pGlu-(D/L)Agl(X)-Pro-
NH2 where Agl = aminoglycine. Analogs ranged from X being a proton to an ac
ylating agent derived from substituted (aromatic heterocyclic rings) formic
or acetic acids or an aminotriazolyl moiety (3'-amino-1H-1',2',4'-triazoly
l) built on N-alpha of aminoglycine or N-beta of alpha,beta-diaminoproprion
ic acid (Dpr). X was expected to mimic the electronic and structural charac
teristics of the imidazole ring of histidine. Analogs were purified by HPLC
, characterized by mass spectrometry and isolated as either diastereoisomer
ic mixtures or pure isomers. Analogs, tested for their binding affinity to
mouse pituitary TRH receptors, have apparent equilibrium inhibitory constan
ts >1 mu M. (C) 1998 Elsevier Science Inc.